Humphrey Rachel's Form 4 filing
Pyxis Oncology, Inc. (PYXS) · filed Mar 25, 2026
- Accession no.
- 0000905148-26-001434
- Filed
- Mar 25, 2026
- Trade date
- Apr 14-21, 2025
- Filing delay
- 345 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $15.9K. It was filed 345 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Humphrey RachelCIK 0001579781 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | Common Stock | SSaleDisposed | −1,400 | $0.97 | −$1,358 | 95,405 | Direct | |
| Apr 17, 2025 | Common Stock | SSaleDisposed | −200 | $0.97 | −$194 | 95,205 | Direct | |
| Apr 21, 2025 | Common Stock | SSaleDisposed | −13,896 | $1.03 | −$14,312.88 | 81,309 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.